Red cell distribution width predicts contrast-induced nephropathy in patients undergoing percutaneous coronary

Alparslan Kurtul1, Mikail Yarlioglues2, Sani Namik Murat2

  • 1Department of Cardiology, Ankara Education and Research Hospital, Ankara, Turkey alpkurtul@yahoo.com.

Angiology
|May 20, 2014
PubMed

Insights

Elevated red cell distribution width (RDW) is linked to a higher risk of contrast-induced nephropathy (CIN) in acute coronary syndrome (ACS) patients undergoing percutaneous coronary intervention (PCI). This finding may help identify at-risk individuals.

Area of Science:

  • Cardiology
  • Nephrology
  • Clinical Medicine

Background:

  • Contrast-induced nephropathy (CIN) is a complication following percutaneous coronary intervention (PCI).
  • Predictive markers for CIN in acute coronary syndrome (ACS) patients are crucial for risk stratification.

Purpose of the Study:

  • To investigate the association between red cell distribution width (RDW) and the incidence of CIN.
  • To identify RDW as a potential independent risk factor for CIN in ACS patients undergoing PCI.

Main Methods:

  • A cohort of 662 ACS patients undergoing PCI was retrospectively analyzed.
  • Patients were categorized into CIN and no-CIN groups based on serum creatinine changes post-PCI.
  • Multivariate regression analysis was employed to determine independent risk factors for CIN.

Main Results:

  • CIN developed in 12.2% of patients.
  • Higher baseline RDW, creatinine, and high-sensitivity C-reactive protein levels were observed in the CIN group.
  • Increased RDW was an independent risk factor for CIN (OR 1.379, P = .009).

Conclusions:

  • Elevated baseline RDW is independently associated with an increased risk of CIN in ACS patients undergoing PCI.
  • RDW may serve as a valuable biomarker for predicting CIN development.
  • Further research is warranted to explore the underlying mechanisms and clinical implications.

Related Concept Videos